Progress and prospect of mesenchymal stem cell-based therapy in atherosclerosis
about
Human Gingiva-Derived Mesenchymal Stem Cells Ameliorate Streptozoticin-induced T1DM in mice via Suppression of T effector cells and Up-regulating Treg Subsets.Dichotomous roles of co-stimulatory molecules in diabetes mellitus.Human Gingiva-Derived Mesenchymal Stem Cells Modulate Monocytes/Macrophages and Alleviate Atherosclerosis.Induced pluripotent stem cell-derived mesenchymal stem cells activate quiescent T cells and elevate regulatory T cell response via NF-κB in allergic rhinitis patients.
P2860
Progress and prospect of mesenchymal stem cell-based therapy in atherosclerosis
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Progress and prospect of mesenchymal stem cell-based therapy in atherosclerosis
@ast
Progress and prospect of mesenchymal stem cell-based therapy in atherosclerosis
@en
Progress and prospect of mesenchymal stem cell-based therapy in atherosclerosis
@nl
type
label
Progress and prospect of mesenchymal stem cell-based therapy in atherosclerosis
@ast
Progress and prospect of mesenchymal stem cell-based therapy in atherosclerosis
@en
Progress and prospect of mesenchymal stem cell-based therapy in atherosclerosis
@nl
prefLabel
Progress and prospect of mesenchymal stem cell-based therapy in atherosclerosis
@ast
Progress and prospect of mesenchymal stem cell-based therapy in atherosclerosis
@en
Progress and prospect of mesenchymal stem cell-based therapy in atherosclerosis
@nl
P2093
P2860
P1476
Progress and prospect of mesenchymal stem cell-based therapy in atherosclerosis
@en
P2093
P2860
P304
P407
P577
2016-10-15T00:00:00Z